Literature DB >> 29800017

Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Stacy Loeb1, Nataliya Byrne2, Danil V Makarov1, Herbert Lepor2, Dawn Walter3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800017      PMCID： PMC6134433          DOI： 10.1001/jama.2018.5616

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

Authors:  Matthew R Cooperberg; Peter R Carroll
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

2.  Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.

Authors:  Gregory B Auffenberg; Brian R Lane; Susan Linsell; Michael L Cher; David C Miller
Journal:  JAMA Surg       Date:  2017-10-01       Impact factor: 14.766

3.  Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.

Authors:  Marco Moschini; Nicola Fossati; Akshay Sood; Justin K Lee; Jesse Sammon; Maxine Sun; Dan Pucheril; Deepansh Dalela; Francesco Montorsi; R Jeffrey Karnes; Alberto Briganti; Quoc-Dien Trinh; Mani Menon; Firas Abdollah
Journal:  Eur Urol Focus       Date:  2016-06-14

4.  Qualitative study on decision-making by prostate cancer physicians during active surveillance.

Authors:  Stacy Loeb; Caitlin Curnyn; Angela Fagerlin; Ronald Scott Braithwaite; Mark D Schwartz; Herbert Lepor; Herbert Ballentine Carter; Erica Sedlander
Journal:  BJU Int       Date:  2016-10-02       Impact factor: 5.588

5.  Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

Authors:  Ronald C Chen; R Bryan Rumble; D Andrew Loblaw; Antonio Finelli; Behfar Ehdaie; Matthew R Cooperberg; Scott C Morgan; Scott Tyldesley; John J Haluschak; Winston Tan; Stewart Justman; Suneil Jain
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

6.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.

Authors:  Stacy Loeb; Yasin Folkvaljon; Caitlin Curnyn; David Robinson; Ola Bratt; Pär Stattin
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777
  6 in total
  22 in total

1.  Reconsidering the Trade-offs of Prostate Cancer Screening.

Authors:  Jonathan E Shoag; Yaw A Nyame; Roman Gulati; Ruth Etzioni; Jim C Hu
Journal:  N Engl J Med       Date:  2020-06-18       Impact factor: 91.245

2.  Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.

Authors:  Brandon A Mahal; Santino Butler; Idalid Franco; Daniel E Spratt; Timothy R Rebbeck; Anthony V D'Amico; Paul L Nguyen
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

3.  Best of the 2018 AUA Annual Meeting.

Authors:  Zeyad R Schwen; Alan W Partin
Journal:  Rev Urol       Date:  2018

4.  Veterans Affairs Health Care-It is the Local Market.

Authors:  Kyle H Sheetz; Carolyn M Clancy
Journal:  Health Serv Res       Date:  2018-07-31       Impact factor: 3.402

5.  Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Authors:  Richard M Hoffman; Tania Lobo; Stephen K Van Den Eeden; Kimberly M Davis; George Luta; Amethyst D Leimpeter; David Aaronson; David F Penson; Kathryn Taylor
Journal:  Med Decis Making       Date:  2019-10-21       Impact factor: 2.583

6.  Active treatment in low-risk prostate cancer: a population-based study.

Authors:  S Roy; M E Hyndman; B Danielson; A Fairey; R Lee-Ying; W Y Cheung; A R Afzal; Y Xu; T Abedin; H C Quon
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 7.  Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.

Authors:  Stacy Loeb; Nataliya K Byrne; Binhuan Wang; Danil V Makarov; Daniel Becker; David R Wise; Herbert Lepor; Dawn Walter
Journal:  Eur Urol       Date:  2020-02-22       Impact factor: 20.096

8.  Trends in treatments for prostate cancer in the United States, 2010-2015.

Authors:  Jianwei Wang; Harry Hua-Xiang Xia; Yuanyuan Zhang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2021-05-20       Impact factor: 6.166

9.  Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.

Authors:  Ericka M Sohlberg; I-Chun Thomas; Jaden Yang; Kristopher Kapphahn; Timothy J Daskivich; Ted A Skolarus; Jeremy B Shelton; Danil V Makarov; Jonathan Bergman; Christine Ko Bang; Mary K Goldstein; Todd H Wagner; James D Brooks; Manisha Desai; John T Leppert
Journal:  Urol Oncol       Date:  2020-07-13       Impact factor: 3.498

10.  Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer.

Authors:  Rachael L Sherrer; Zachary A Glaser; Jennifer B Gordetsky; Jeffrey W Nix; Kristin K Porter; Soroush Rais-Bahrami
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-11-09       Impact factor: 5.554
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.